HESKA CORPORATION (NASDAQ:HSKA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02
|
Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
of Directors (the Compensation Committee) of Heska Corporation, a
Delaware corporation (the Company), amended the Companys stock
option agreement and restricted stock grant agreement forms to be
used for grants of awards to its employees, consultants and
outside directors, as applicable, under or in connection with the
Companys 1997 Stock Incentive Plan, as amended and restated (the
1997 Plan), the Companys 2003 Equity Incentive Plan, as amended
and restated (the 2003 Plan), and the Companys Amended and
Restated Management Incentive Plan. The amendments were intended
to make consistent among the several forms the vesting provisions
in the case of a participants death or disability or a change in
control of the Company, and to make other minor conforming
changes. The foregoing summary is qualified in its entirety by
reference to the full text of each of the form agreements, a copy
of each of which is attached hereto as an exhibit and is
incorporated herein by reference thereto.
Compensation Committee granted stock option awards under the 1997
Plan to each of Messrs. Napolitano, McGinley, Eyl and McMahon,
and Ms. Wisnewski. These executive officers were granted the
option to purchase 15,000 shares, 11,400 shares, 15,000 shares,
11,400 shares, and 11,400 shares of the Companys common stock,
respectively. The stock option awards vest in equal monthly
installments over a four-year period through December 28, 2020,
expire ten years after the day prior to the initial grant date,
and were issued with an exercise price per share of $72.85, which
amount was the closing price per share of the Companys common
stock as reported on the Nasdaq Stock Market on the date of
grant.
|
Exhibit Number:
|
Exhibit Description:
|
|
|
99.1
|
Form of Stock Option Agreement (employees and
consultants) under the 1997 Plan |
|
|
99.2
|
Form of Non-Qualified Stock Option Agreement (outside
directors) under the 1997 Plan |
|
|
99.3
|
Form of Restricted Stock Grant Agreement under the 1997
Plan |
|
|
99.4
|
Form of Restricted Stock Grant Agreement under 1997
Plan (Management Incentive Plan Award) |
|
|
99.5
|
Form of Stock Option Agreement (employees and
consultants) under the 2003 Plan |
|
|
99.6
|
Form of Non-Qualified Stock Option Agreement (outside
directors) under the 2003 Plan |
|
|
99.7
|
Form of Restricted Stock Grant Agreement under the 2003
Plan |
|
|
99.8
|
Form of Restricted Stock Grant Agreement under the 2003
Plan (Management Incentive Plan Award) |
|
About HESKA CORPORATION (NASDAQ:HSKA)
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. HESKA CORPORATION (NASDAQ:HSKA) Recent Trading Information
HESKA CORPORATION (NASDAQ:HSKA) closed its last trading session down -1.85 at 71.00 with 33,259 shares trading hands.